Nano Mask, Inc. announces that it has launched a complete line of Nano Silver Technology Hospital Curtains which is being manufactured by an ISO 2010 certified manufacturer. The complete line is now available for sale in the United States and Europe.
Nano Silver Technology is an antimicrobial colloid composed of silver nanoparticles stabilized by polymer that exhibits excellent antimicrobial efficacy across a wide spectrum of microorganisms. Silver has long been known to inhibit the oxygen exchange in bacteria, killing the bacteria. Nano Silver Technology has been demonstrated to prolong and enhance that effect. Its super-charged magnetic attraction pulls the abnormal DNA of viruses, so it cannot reproduce, thus killing viruses.
In testing, Nano Silver Technology testing has demonstrated the ability to eradicate Staphylococcus aureus, ATCC 6538P and Klebsiella pneumonia and ATCC 4352. In addition, the Nano Silver Curtains are flame-proof (Type C), anti-static, dust-proof; disposable; recyclable, and mildew-proof and are available in three different styles and 13 different colors.
Â
Nano Mask believes that the introduction of this advanced anti-bacterial technology may reduce the risk to patients, staff and visitors of hospital-acquired infections by eliminating certain pathogens, molds and fungi that come into contact with the curtain. In most cases Nano Mask believes its Nano Silver Technology Curtains offer a considerable cost saving when compared to conventional systems and will not only help to saves lives and reduce clinical costs (including infection treatment costs), but will also reduce capital, labor and laundry costs. Nano Mask plans to launch this product in the United States and international markets immediately through its network of distributors and manufacturers' representatives servicing the hospital market.
For more information, visit www.nanoprotectionsolutions.com
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.